Update in Critical Care Medicine
- Kalpalatha K. Guntupalli, MD; and
- Robert E. Fromm, Jr., MD, MPH
- From Ben Taub General Hospital and Baylor College of Medicine, Houston, Texas.
- Respiration, artificial
- Nitric oxide
- Respiratory distress syndrome, adult
- Thromboembolism
- Pneumonia, pneumocystis carinii
1999-2000 Series: Update Sessions from ACP-ASIM's 1999 Annual Session
Margaret Ring Gillock, Editor, and David Cramer, MD, Co-Editor
We begin this survey with reports describing advances in mechanical ventilatory assistance, including maximization of oxygenation by inhaled nitric oxide and a lung-protective ventilatory regimen that seems to improve the outlook for patients with the acute respiratory distress syndrome (ARDS). We also discuss extubation, both planned (by use of a simple index of readiness) and unplanned. Reports dealing with sepsis and infection cover the detection of Pneumocystis carinii infection by endotracheal aspiration and the dependence of survival on how well a patient can utilize oxygen. Another topic covered is the value of gastrointestinal decontamination in the intensive care unit (ICU). The subject of thromboembolism is represented by a meta-analysis seeking to learn whether prophylactic heparin can prevent catheter-related venous thrombosis and by a trial combining heparin with a vena caval filter in patients with deep venous thrombosis. Finally, other interesting reports address how often autopsies of patients in a coronary ICU reveal important unexpected findings, whether colloid fluid is really better than crystalloid fluid, the value of intensivist care in the medical ICU, and a simple preadmission tool for predicting the outcome of gastrointestinal bleeding.
Mechanical Ventilation
Inhaled Nitric Oxide Substantially Improved Oxygenation but not Clinical Outcomes in Patients with the Acute Respiratory Distress Syndrome
Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med. 1998; 26:15-23.
Nitric oxide (NO) is an endogenous endothelium-derived smooth-muscle relaxant and, as such, a potent vasodilator. The very short half-life of inhaled NO has made it an effective treatment for various forms of pulmonary hypertension. Pulmonary hypertension may contribute to pulmonary edema and dysfunction in patients with ARDS, raising the possibility that inhalation of NO could promote blood flow to well-ventilated areas by dilating the pulmonary …
RSS Feeds









